STOCK TITAN

Globe Life Inc Form 4 Filings

GL NYSE

Every Form 4 that Globe Life Inc (GL) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow GL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GL filings page.

Rhea-AI Summary

GLOBE LIFE INC. executive Michael Clay Majors, EVP and Chief Strategy Officer, reported a Form 4 transaction involving a tax-related share disposition. On February 22, 2026, 508 shares of Globe Life common stock were disposed of at $144.39 per share to satisfy tax withholding obligations, rather than as an open-market sale. After this transaction, Majors directly owned 46,569.447 shares of common stock. A footnote explains that this direct total includes 11.447 dividend equivalent restricted stock units tied to restricted stock units granted in 2025 and 2026.

Rhea-AI Summary

GLOBE LIFE INC. executive Jennifer Allison Haworth, EVP & Chief Marketing Officer, reported a Form 4 showing a tax-withholding disposition of 760 shares of common stock on February 22, 2026. The shares were delivered at a price of $144.39 per share to satisfy tax obligations, rather than sold in an open-market trade.

After this transaction, she directly owned 16,727.7195 shares of common stock, which the filing notes includes 8.7195 dividend equivalent restricted stock units linked to restricted stock units granted in 2025 and 2026. She also held 1,972.5760 shares indirectly through a Thrift/401(k) Plan Trust.

Rhea-AI Summary

GLOBE LIFE INC. senior vice president and chief accounting officer Michael Shane Henrie reported a Form 4 transaction involving company common stock. On February 22, 2026, 174 shares were disposed of at $144.39 per share in a tax-withholding disposition related to equity compensation. After this, his directly held common stock totaled 2,876.0833 shares, which the footnote explains includes 10.0833 dividend-equivalent restricted stock units acquired on restricted stock units in 2025 and 2026. He also reports indirect ownership of 157.19 shares held through a 401(k) plan.

Rhea-AI Summary

GLOBE LIFE INC. reported that Co-Chairman & CEO Frank M. Svoboda had a tax-withholding disposition of 1,327 shares of common stock on February 22, 2026 at $144.3900 per share, coded as a payment of tax liability by delivering securities. After this transaction, he held 34,571.4648 shares directly, which include 30.4648 dividend equivalent restricted stock units tied to prior awards. He also reported indirect holdings of 108,473.0000 shares through a Family Trust, 26,425.0000 shares through a Spouse's Irrevocable Trust, and 1,951.1300 shares through a 401(k) Plan.

Rhea-AI Summary

Globe Life Inc. director and Co-Chairman & CEO James Matthew Darden reported a tax-related share disposition. On February 22, 2026, 1,343 shares of common stock were disposed of at $144.39 per share to satisfy tax withholding obligations. After this transaction, he held 48,529.4598 shares directly and 4,185.585 shares indirectly through a 401(k) plan, which include a small number of dividend equivalent restricted stock units.

Rhea-AI Summary

GLOBE LIFE INC. Co-Chairman & CEO Frank M. Svoboda reported exercising employee stock options for 12,500 shares on 2026-02-17, acquiring common stock at an exercise price of $82.5600 per share. This increased his directly held common stock before subsequent sales.

On the same date, he sold a total of 12,500 common shares in open-market transactions, in three blocks of 3,595, 6,451 and 2,454 shares at average prices of $143.9489, $144.9556 and $145.5165 per share, leaving 35,868 shares held directly. He also reports indirect ownership of 108,473 shares through a Family Trust, 26,425 shares through a Spouse's Irrevocable Trust, and 1,951.130 shares through a 401(k) Plan.

Rhea-AI Summary

Globe Life Inc. executive Jennifer A. Haworth, EVP & Chief Marketing Officer, exercised an employee stock option for 10,000 shares of common stock at an exercise price of $50.64 per share on February 12, 2026. She then sold 10,000 shares of Globe Life common stock in multiple open-market transactions the same day at prices ranging from $141.595 to $144.075 per share. Following these transactions, she directly owned 17,479 shares of common stock and indirectly held 1,938.443 shares through a Thrift/401(k) Plan trust.

Rhea-AI Summary

Globe Life Inc. executive vice president and chief financial officer Thomas P. Kalmbach reported acquiring 7,537 shares of Globe Life common stock on February 26, 2025 at a reported price of $0, leaving him with 25,780.945 shares beneficially owned directly after the transaction.

The amended filing states this total includes 17.136 shares acquired through the company’s dividend reinvestment plan since the last report and clarifies that the amendment was made to correct the beneficial ownership amount, which also affects one subsequent filing.

Rhea-AI Summary

Globe Life Inc. director Mark A. Blinn reported an indirect sale of common stock through a trust. On 02/06/2026, the trust sold 1,750 Globe Life shares at $147.91 per share. After the sale, Blinn held 1,373 shares directly and 3,372 shares indirectly through the trust.

Rhea-AI Summary

Globe Life Inc. director amends prior insider trade report to clarify ownership. The amended Form 4 shows that on January 6, 2025, a trust associated with the director sold 3,000 shares of Globe Life common stock at $113.235 per share.

After the sale, the director holds 1,604 shares directly and 3,518 shares indirectly through the trust. The amendment corrects the earlier filing to state that the transaction was executed from the reporting person's trust account rather than from a direct personal holding.

Rhea-AI Summary

Globe Life Inc. director Mark A. Blinn reported an amended insider transaction. On 04/25/2024, a trust associated with him purchased 2,000 shares of Globe Life common stock at $76.77 per share. The amendment corrects the attribution of beneficial ownership to the reporting person’s trust.

After this transaction, the filing shows 5,043 shares of Globe Life common stock held indirectly through the trust and 1,475 shares held directly by Blinn.

Rhea-AI Summary

Globe Life Inc. executive Michael Clay Majors, EVP and Chief Strategy Officer, reported stock option exercises and share sales dated February 6, 2026. He exercised employee stock options for 27,000 shares at $100.74 per share and 3,000 shares at $98.32 per share, receiving common stock.

On the same date he sold several blocks of common stock, including 11,581, 13,510, 3,488 and 1,421 shares at weighted average prices of about $146.04, $147.18, $147.92 and $148.63 per share, with detailed price ranges disclosed in the footnotes. After these transactions he directly owned 47,066 Globe Life shares and reported 0 shares held indirectly.

Rhea-AI Summary

Globe Life Inc. director Matthew J. Adams filed an amended insider report after acquiring additional company stock. On January 2, 2026, he acquired 1,373 shares of Globe Life common stock at a reported price of $0 per share, increasing his direct holdings.

Following this transaction, Adams now beneficially owns 2,558.3971 Globe Life shares directly and holds no shares indirectly. The amendment clarifies that this total was corrected to include 2.3971 shares previously acquired through the company’s dividend reinvestment plan, while noting that the original filing was submitted on time.

Rhea-AI Summary

Globe Life Inc. (GL) director reports stock acquisition

A Globe Life Inc. director, Marilyn A. Alexander, reported acquiring 458 shares of the company’s common stock on 01/02/2026 at a stated price of $0 per share. After this transaction, she beneficially owns 22,606.7364 shares of Globe Life common stock in direct ownership.

The footnote explains that this total includes 102.7315 dividend right restricted stock units that were acquired on restricted stock units since the date of the last report. No derivative securities transactions were reported in this filing.

Rhea-AI Summary

Globe Life Inc. (GL) director reports stock acquisition

A director of Globe Life Inc., Linda L. Addison, reported acquiring 723 shares of Globe Life common stock on 01/02/2026 in a transaction coded "A" at a price of $0 per share. Following this transaction, she beneficially owns 20,406.1005 shares of Globe Life common stock in direct form. The filing notes that this total includes 140.5747 dividend right restricted stock units that were acquired in connection with restricted stock units since the date of the last report.

Rhea-AI Summary

Globe Life Inc. director reports acquisition of company stock

A Globe Life Inc. director reported acquiring 1,373 shares of the company’s common stock on 01/02/2026 at a stated price of $0 per share. Following this transaction, the director beneficially owns 10,835.951 shares directly and no shares indirectly. The filing notes that this total includes 52.429 shares acquired through the company’s dividend reinvestment plan since the date of the last report.

Rhea-AI Summary

Globe Life Inc. director reports stock acquisition

A director of Globe Life Inc. reported acquiring 1,373 shares of the company’s common stock on 01/02/2026 at a reported price of $0 per share. After this transaction, the director beneficially owns 18,747.3763 shares directly. The filing notes that this total includes 108.1129 shares accumulated through the company’s dividend reinvestment plan since the prior report.

Rhea-AI Summary

Globe Life Inc. director Alice S. Cho reported acquiring company stock in an insider transaction. On 01/02/2026, she acquired 1,373 shares of Globe Life common stock at a reported price of $0, indicating an equity award rather than an open-market purchase. Following this transaction, she beneficially owned 5,877.0607 shares of Globe Life common stock in direct ownership.

The footnote explains that this total includes 37.1003 dividend right restricted stock units that were acquired in connection with restricted stock units since the date of the last report, showing that part of the position is tied to equity-based compensation that accrues dividend equivalents.

Rhea-AI Summary

Globe Life Inc. director reports new stock grant and updated holdings. A company director acquired 1,373 shares of Globe Life common stock on 01/02/2026 at a stated price of $0, reflecting an equity-based award rather than an open-market purchase. Following this transaction, the director beneficially owns 10,102.564 shares directly and holds no shares indirectly. The reported holdings include 55.4319 dividend-right restricted stock units that were acquired in connection with restricted stock units since the prior report.

Rhea-AI Summary

Globe Life Inc. director David A. Rodriguez reported acquiring common stock of the company. On 01/02/2026, he acquired 1,373 shares of common stock at a stated price of $0, which typically reflects an equity award rather than an open‑market purchase. Following this transaction, he beneficially owned 7,226.4852 shares of Globe Life common stock directly.

An explanatory note states that this amount includes 35.8599 dividend right restricted stock units that were acquired in connection with restricted stock units since the date of his last report.

Rhea-AI Summary

Globe Life Inc. director Philip M. Jacobs reported acquiring 1,373 shares of common stock on 01/02/2026 at a stated price of $0, indicating a stock grant rather than an open-market purchase. Following this transaction, he beneficially owns 2,563.4851 shares directly. The filing notes that this total includes 7.4851 dividend right restricted stock units that were accrued since the prior report.

Rhea-AI Summary

Globe Life Inc. director reports stock acquisition

A Form 4 reports that director Mark A. Blinn acquired 1,373 shares of Globe Life Inc. common stock on 01/02/2026. The transaction is coded as an acquisition and shows a price of $0 per share, indicating the shares were received without cash payment, such as through an award or similar grant. After this transaction, he beneficially owned 6,495 shares of Globe Life common stock in direct ownership. The filing indicates there are no indirectly owned shares reported.

Rhea-AI Summary

Globe Life Inc. director Matthew J. Adams reported an acquisition of company stock. On 01/02/2026, he received 1,373 shares of Globe Life common stock in a transaction coded "A," which indicates an acquisition such as a grant or award. The shares were recorded at a price of $0, consistent with a non-cash equity grant.

After this transaction, Adams beneficially owned 2,556 shares of Globe Life common stock in direct ownership. The filing also notes that he had 0 shares held indirectly, described as "Not Applicable" for the nature of indirect beneficial ownership. The form is filed for one reporting person and reflects his status as a director of Globe Life Inc.

Rhea-AI Summary

Globe Life Inc. insider Frank M. Svoboda, who serves as Co-Chairman, CEO and Director, reported changes in his indirect ownership of the company’s common stock. On 12/19/2025, 26,425 shares were transferred at a price of $0 from a family trust, where the holdings are now reported as 108,473 shares held indirectly, to his spouse's irrevocable trust, which now holds 26,425 shares indirectly. The filing also reports 35,868 shares of common stock and 1,947.384 shares held indirectly through a 401(k) plan following the reported transactions.

Rhea-AI Summary

Globe Life Inc. reported insider stock transactions by Co-Chairman, CEO and Director Frank M. Svoboda on December 16, 2025. He exercised an employee stock option to acquire 12,500 shares of common stock at an exercise price of $82.56 per share, then sold portions of those shares on the same day.

The reported sales totaled 6,579 shares at a price shown as $140.2742 per share, with actual sale prices ranging from $139.65 to $140.64, and an additional 2,800 shares at $140.7887 per share, with prices ranging from $140.65 to $141.03. After these transactions, he directly owned 35,868 Globe Life common shares, plus 134,898 shares held through a family trust and 1,947.384 shares through a 401(k) plan.

Rhea-AI Summary

Globe Life Inc. executive Michael Shane Henrie, SVP & Chief Accounting Officer, reported an option exercise and share sale on 07/29/2025. He exercised employee stock options for 3,250 shares of common stock at $103.23 per share, then sold 3,250 shares at a weighted average price of $139.7526, with individual trades between $139.67 and $139.90.

After these transactions, he directly owned 3,040 Globe Life shares and held an additional 152.182 shares indirectly through a 401(k) plan. The amended report also corrects the amount of underlying securities shown for the employee stock option in Table II, while noting that the original report was filed on time.

Rhea-AI Summary

Globe Life Inc. officer Michael Shane Henrie, the company’s SVP and Chief Accounting Officer, reported exercising stock options and selling common shares on 12/12/2025.

He exercised 3,065 employee stock options at an exercise price of $120.49 per share and sold 3,065 shares of Globe Life common stock at a weighted average price of $139.0997 per share, with sale prices ranging from $138.87 to $139.325. After these transactions, he directly owned 3,040 shares of common stock and indirectly held 154.904 shares through a 401(k) plan. The Form 4 also lists 3,065 employee stock options expiring on 02/22/2030, which were first exercisable as to 50% of the shares on 02/22/2025 and the remaining 50% on 02/22/2026.

Rhea-AI Summary

Globe Life Inc. (GL) executive Robert Brian Mitchell, EVP, General Counsel and CRO, reported gift transactions on 11/13/2025 (Transaction Code G). The filing shows a disposition of 2,091 shares of common stock at $0 from the Mitchell Family Trust, and an acquisition of 283 shares at $0 into an irrevocable trust for his son.

Following these transactions, reported holdings were 39,042.3294 shares indirect via the Mitchell Family Trust, 1,853.3929 shares indirect via the Son's Trust, 12,303.005 shares indirect via the Thrift Plan Trust, and 8,074 shares held directly. The footnotes note 3.1994 shares added through a brokerage dividend reinvestment plan since the last report, and that of the 2,091 shares gifted by the family trust, 283 shares were gifted to the son's irrevocable trust.

Rhea-AI Summary

Globe Life Inc. (GL) reported an insider transaction by EVP, General Counsel and CRO Robert Brian Mitchell on 10/24/2025. He exercised employee stock options at $100.74, $98.32 and $103.23, acquiring 38,000, 38,000 and 15,000 shares of common stock. He then sold 40,185 shares at an average price of $133.8686 and 50,815 shares at an average price of $134.5964.

Following these transactions, his direct ownership was 8,074 shares. Indirect holdings were 41,133.3294 shares in the Mitchell Family Trust, 1,580.7839 shares in a Son's Trust, and 12,274.832 shares in a 401(k) Plan.

Rhea-AI Summary

Dolores L. Skarjune, EVP and Chief Administrative Officer of Globe Life Inc. (GL), reported option exercises and a sale on 09/12/2025. She exercised options to acquire 2,100 shares at $82.56 and 2,400 shares at $98.32, and sold 4,500 shares at $142.52. Following these transactions she directly beneficially owns 9,417 shares and indirectly holds 2,701.527 shares through a 401(k) plan, for a combined reported position of 13,917 shares.

Rhea-AI Summary

Dolores L. Skarjune, Executive Vice President and Chief Administrative Officer of Globe Life Inc. (GL), reported multiple transactions dated 09/10/2025. She exercised an employee stock option to acquire 6,200 shares at an exercise price of $103.23 per share. On the same date she sold 3,354 shares at prices ranging from $139.31 to $140.01 and sold an additional 1,620 shares at prices ranging from $140.015 to $140.49. After these transactions she beneficially owned 11,037 shares directly and 2,701.527 shares indirectly through a 401(k) plan. The Form 4 was signed by an attorney-in-fact on 09/11/2025.